• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $BIRD

    Allbirds Inc.

    Subscribe to $BIRD
    $BIRD
    Apparel
    Consumer Discretionary

    Allbirds, Inc. manufactures and sells footwear and apparel products for men and women. It offers shoes, such as running shoes, everyday sneakers, high-tops, slip-ons, boat shoes, flats, weather repellent shoes, and sandals. The company's apparel products include activewear, tops, bottoms, dresses, sweaters, underwear, and socks. It sells its products through its retail stores in the United States and internationally, as well as online. Allbirds, Inc. was formerly known as Bozz, Inc. The company was incorporated in 2015 and is based in San Francisco, California.

    IPO Year: 2021

    Exchange: NASDAQ

    Website: allbirds.com

    Recent Analyst Ratings for Allbirds Inc.

    DatePrice TargetRatingAnalyst
    4/11/2025$14.00Buy
    Maxim Group
    5/1/2023$1.50Market Perform → Outperform
    Telsey Advisory Group
    3/13/2023$4.00 → $1.50Outperform → Market Perform
    TD Cowen
    3/10/2023$4.00 → $2.25Outperform → Market Perform
    Telsey Advisory Group
    3/10/2023Buy → Neutral
    Guggenheim
    3/10/2023Outperform → Mkt Perform
    William Blair
    3/6/2023$3.00Outperform → Neutral
    Wedbush
    2/7/2023Neutral
    BTIG Research
    1/5/2023$5.00 → $4.00Overweight → Neutral
    Piper Sandler
    8/10/2022$12.00 → $5.00Overweight → Equal-Weight
    Morgan Stanley
    See more ratings